282 related articles for article (PubMed ID: 16741573)
1. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
Flowers MT; Miyazaki M; Liu X; Ntambi JM
J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
[TBL] [Abstract][Full Text] [Related]
2. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
3. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
4. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
5. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis.
Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen T; Zhu X; Duong MN; Wibley AL; Shah R; Davis MA; Kelley K; Wilson MD; Kent C; Parks JS; Rudel LL
Circulation; 2008 Sep; 118(14):1467-75. PubMed ID: 18794388
[TBL] [Abstract][Full Text] [Related]
7. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
[TBL] [Abstract][Full Text] [Related]
9. Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice.
Singh V; Chassaing B; Zhang L; San Yeoh B; Xiao X; Kumar M; Baker MT; Cai J; Walker R; Borkowski K; Harvatine KJ; Singh N; Shearer GC; Ntambi JM; Joe B; Patterson AD; Gewirtz AT; Vijay-Kumar M
Cell Metab; 2015 Dec; 22(6):983-96. PubMed ID: 26525535
[TBL] [Abstract][Full Text] [Related]
10. The role of suppression of hepatic SCD1 expression in the metabolic effects of dietary methionine restriction.
Forney LA; Stone KP; Wanders D; Ntambi JM; Gettys TW
Appl Physiol Nutr Metab; 2018 Feb; 43(2):123-130. PubMed ID: 28982014
[TBL] [Abstract][Full Text] [Related]
11. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
12. The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation.
Sampath H; Ntambi JM
Ann N Y Acad Sci; 2011 Dec; 1243():47-53. PubMed ID: 22211892
[TBL] [Abstract][Full Text] [Related]
13. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.
Stefan N; Peter A; Cegan A; Staiger H; Machann J; Schick F; Claussen CD; Fritsche A; Häring HU; Schleicher E
Diabetologia; 2008 Apr; 51(4):648-56. PubMed ID: 18286258
[TBL] [Abstract][Full Text] [Related]
14. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
[TBL] [Abstract][Full Text] [Related]
15. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.
Pinnamaneni SK; Southgate RJ; Febbraio MA; Watt MJ
Diabetologia; 2006 Dec; 49(12):3027-37. PubMed ID: 17033839
[TBL] [Abstract][Full Text] [Related]
16. The role of stearoyl-CoA desaturase in the control of metabolism.
Dobrzyn A; Ntambi JM
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):35-41. PubMed ID: 15941655
[TBL] [Abstract][Full Text] [Related]
17. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
Flowers MT; Ntambi JM
Curr Opin Lipidol; 2008 Jun; 19(3):248-56. PubMed ID: 18460915
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatic desaturases in obesity-related metabolic disorders.
Bjermo H; Risérus U
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):703-8. PubMed ID: 20823776
[TBL] [Abstract][Full Text] [Related]
19. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
[TBL] [Abstract][Full Text] [Related]
20. The role of stearoyl-CoA desaturase in body weight regulation.
Dobrzyn A; Ntambi JM
Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
